Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaru Mimura

Showing results (81-90 of 726) with videos related to

Pageof 73
Sort By:
Psychosomatic Medicine|March 10, 2018
Catatonic Stupor in Schizophrenic Disorders and Subsequent Medical Complications and MortalityMichitaka Funayama, Taketo Takata, Akihiro Koreki, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 16, 2018
Exercise program improved subjective dry eye symptoms for office workersKokoro Sano, Motoko Kawashima, Sayuri Takechi, et al.
Neuropsychopharmacology Reports|June 4, 2020
Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross-sectional studyKie Takahashi, Ryoko Yamazawa, Takefumi Suzuki, et al.
Journal of Clinical Pharmacology|January 28, 2016
Early Improvements in Individual Symptoms to Predict Later Remission in Major Depressive Disorder Treated With MirtazapineKei Funaki, Shinichiro Nakajima, Takefumi Suzuki, et al.
Expert Opinion on Pharmacotherapy|March 1, 2022
Pharmacotherapeutic combinations for the treatment of Alzheimer's diseaseTomoyuki Nagata, Shunichiro Shinagawa, Shinichiro Nakajima, et al.
The International Journal of Neuropsychopharmacology|May 9, 2017
A New Paradigm for Evaluating Avoidance/Escape MotivationIku Tsutsui-Kimura, Youcef Bouchekioua, Masaru Mimura, et al.
Psychopharmacology|May 5, 2017
Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D dataHitoshi Sakurai, Takefumi Suzuki, Kimio Yoshimura, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|August 10, 2020
Comparison of various items of the quality of life in Alzheimer's disease scale (QOL-AD) in patients with mild or moderate stages of dementia: a cross-sectional studyRyo Shikimoto, Shutaro Nakaaki, Junko Sato, et al.
Schizophrenia Research|December 14, 2011
Antipsychotic treatment for schizophrenia in the maintenance phase: a systematic review of the guidelines and algorithmsHiroyoshi Takeuchi, Takefumi Suzuki, Hiroyuki Uchida, et al.
Pharmacopsychiatry|October 18, 2022
Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-AnalysisAkira Nishi, Kyosuke Sawada, Hiroyuki Uchida, et al.
Pageof 73

Showing results (81-90 of 726) with videos related to

Sort By:
Pageof 73
Psychosomatic Medicine|March 10, 2018
Catatonic Stupor in Schizophrenic Disorders and Subsequent Medical Complications and MortalityMichitaka Funayama, Taketo Takata, Akihiro Koreki, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 16, 2018
Exercise program improved subjective dry eye symptoms for office workersKokoro Sano, Motoko Kawashima, Sayuri Takechi, et al.
Neuropsychopharmacology Reports|June 4, 2020
Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross-sectional studyKie Takahashi, Ryoko Yamazawa, Takefumi Suzuki, et al.
Journal of Clinical Pharmacology|January 28, 2016
Early Improvements in Individual Symptoms to Predict Later Remission in Major Depressive Disorder Treated With MirtazapineKei Funaki, Shinichiro Nakajima, Takefumi Suzuki, et al.
Expert Opinion on Pharmacotherapy|March 1, 2022
Pharmacotherapeutic combinations for the treatment of Alzheimer's diseaseTomoyuki Nagata, Shunichiro Shinagawa, Shinichiro Nakajima, et al.
The International Journal of Neuropsychopharmacology|May 9, 2017
A New Paradigm for Evaluating Avoidance/Escape MotivationIku Tsutsui-Kimura, Youcef Bouchekioua, Masaru Mimura, et al.
Psychopharmacology|May 5, 2017
Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D dataHitoshi Sakurai, Takefumi Suzuki, Kimio Yoshimura, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|August 10, 2020
Comparison of various items of the quality of life in Alzheimer's disease scale (QOL-AD) in patients with mild or moderate stages of dementia: a cross-sectional studyRyo Shikimoto, Shutaro Nakaaki, Junko Sato, et al.
Schizophrenia Research|December 14, 2011
Antipsychotic treatment for schizophrenia in the maintenance phase: a systematic review of the guidelines and algorithmsHiroyoshi Takeuchi, Takefumi Suzuki, Hiroyuki Uchida, et al.
Pharmacopsychiatry|October 18, 2022
Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-AnalysisAkira Nishi, Kyosuke Sawada, Hiroyuki Uchida, et al.
Pageof 73